Showing results (1-10 of 688) with videos related to

Sort By:
Pageof 69
Diabetes Care|October 1, 1996
LDL apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with hemodialysis treatmentI Inoue, K Takahashi, C Kikuchi, et al.
Biochemical and Biophysical Research Communications|June 4, 1998
Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cellsI Inoue, K Shino, S Noji, et al.
Biochemical and Biophysical Research Communications|August 28, 1997
The peroxisome proliferator-activated receptor alpha (PPAR alpha) regulates the plasma thiobarbituric acid-reactive substance (TBARS) levelI Inoue, S Noji, M Z Shen, et al.
Diabetes Research and Clinical Practice|June 1, 1997
Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitusI Inoue, K Takahashi, S Noji, et al.
Diabetes Research and Clinical Practice|May 16, 2000
Lack of association of the Ala45Thr variant in the BETA2/NEUROD1 with type 1 diabetes in JapaneseT Awata, K Inoue, I Inoue, et al.
Biochemical and Biophysical Research Communications|June 9, 1997
Troglitazone has a scavenging effect on reactive oxygen speciesI Inoue, S Katayama, K Takahashi, et al.
Metabolism: Clinical and Experimental|December 1, 1995
Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed ratsI Inoue, K Takahashi, S Katayama, et al.
Diabetes Research and Clinical Practice|October 1, 1994
Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose toleranceI Inoue, K Takahashi, S Katayama, et al.
Metabolism: Clinical and Experimental|February 15, 2001
The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cellsI Inoue, S Goto, T Matsunaga, et al.
Life Sciences|July 23, 1998
Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu2+, Zn2+-superoxide dismutase in the liverI Inoue, S Noji, T Awata, et al.
Pageof 69